×
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.98 (+1.72%)
AAPL   141.54 (+1.88%)
MSFT   262.90 (+1.28%)
META   168.25 (+5.14%)
GOOGL   2,264.66 (+4.13%)
AMZN   113.36 (+3.47%)
TSLA   701.50 (+2.89%)
NVDA   149.83 (+3.17%)
NIO   22.15 (+3.70%)
BABA   120.29 (+3.70%)
AMD   75.12 (+1.97%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.10 (-0.99%)
GE   62.03 (-2.38%)
F   11.19 (-1.15%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.36 (+4.15%)
NFLX   185.64 (+3.16%)
OTCMKTS:ERFSF

Eurofins Scientific Stock Forecast, Price & News

$77.58
-2.58 (-3.21%)
(As of 07/5/2022 03:44 PM ET)
Add
Compare
Today's Range
$75.32
$77.58
50-Day Range
$77.37
$93.96
52-Week Range
$75.32
$151.96
Volume
970 shs
Average Volume
484 shs
Market Capitalization
$13.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$105.00

Eurofins Scientific MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
31.0% Upside
$105.00 Price Target
Short Interest
Bearish
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.10mentions of Eurofins Scientific in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.52 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

Eurofins Scientific logo

About Eurofins Scientific (OTCMKTS:ERFSF) Stock

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

ERFSF Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CIK
N/A
Fax
N/A
Employees
58,000
Year Founded
N/A

Company Calendar

Today
7/05/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$105.00
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$100.00
Forecasted Upside/Downside
+35.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33333333333333
Research Coverage
9 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.95 billion
Cash Flow
$7.03 per share
Book Value
$23.85 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.81 billion
Optionable
Not Optionable
Beta
0.86














Eurofins Scientific Frequently Asked Questions

Should I buy or sell Eurofins Scientific stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Eurofins Scientific stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View analyst ratings for Eurofins Scientific
or view top-rated stocks.

What is Eurofins Scientific's stock price forecast for 2022?

9 equities research analysts have issued 1-year target prices for Eurofins Scientific's shares. Their ERFSF stock forecasts range from $100.00 to $110.00. On average, they expect Eurofins Scientific's stock price to reach $105.00 in the next twelve months. This suggests a possible upside of 35.3% from the stock's current price.
View analysts' price targets for Eurofins Scientific
or view top-rated stocks among Wall Street analysts.

How has Eurofins Scientific's stock performed in 2022?

Eurofins Scientific's stock was trading at $127.01 at the beginning of the year. Since then, ERFSF shares have decreased by 38.9% and is now trading at $77.58.
View the best growth stocks for 2022 here
.

Who are Eurofins Scientific's key executives?

Eurofins Scientific's management team includes the following people:
  • Dr. Gilles G. Martin Ph.D., Chairman & CEO (Age 59, Pay $1.29M)
  • Ms. Valerie Hanote, Exec. Director (Age 56, Pay $366.23k)
  • Mr. Laurent Lebras, Group Admin. & Fin. Director
  • Ms. Sandra Hoeylaerts, Chief HR Officer
  • Mr. David W. Bryant, Sr. VP of Strategic Bus. Devel. North America
  • Mr. Gabriel Julia, Sr. VP of Clinical Diagnostics Europe
  • Dr. Timothy S. Oostdyk, Exec. VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim Reichelt, Sr. VP of Food & Feed Testing Europe
  • Ms. Yvoine Remy, Sr. VP of Environment Testing Europe
  • Mr. Rajesh Saigal, Exec. VP - Asia

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $77.58.

How much money does Eurofins Scientific make?

Eurofins Scientific (OTCMKTS:ERFSF) has a market capitalization of $13.81 billion and generates $7.95 billion in revenue each year.

How many employees does Eurofins Scientific have?

Eurofins Scientific employs 58,000 workers across the globe.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The official website for Eurofins Scientific is www.eurofins.com. The company can be reached via phone at (522) 618-5320 or via email at ir@eurofins.com.

This page (OTCMKTS:ERFSF) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.